REP1 knockdown with siRNA treatment results in a significant cell growth delay in a nutrient-complete medium using a pancreatic cancer cell line, which was almost rescued when REP1 was overexpressed (Figure 1A and Figure S1). Here, CHM is linked to pancreatic neoplasm.